835(E) dt_Amendment in First Schedule for non clinical testing methods for new drugs (Pluripotent)Ģ022.11.17_Final GSR 823(E)_Amendment in rule 96 for mandating Bar or QR code on the label of top 300 brand in Drugs RulesĢ022.11.02_S.O. 627(E)_Government Analyst Notification at CDTL Hyderabad 175(E)_ Amendment in First Schedule regarding use of induced Pluripotent Stem Cells additional testing methodsĢ023.03.01_DR_Draft_GSR 158(E)_Notification of Gangavaram portĢ023.03.01_MDR_Draft_ GSR 157(E)_Medical Device Rule 18 and 19 Amendment (Central Government and State Government)Ģ023.02.08_S.O. 1928(E)_Notification for testing Covid kit NIB NoidaĢ023.03.09_NDCTR_G.S.R. 364(E)_Notification for registration of Clinical Research Organisation (CRO) 2177(E) _Government Analyst Notification at CDL, KolkataĢ023.05.11_Draft_NDCTR_G.S.R. 3448(E)_Prohibition of Veterinary Drugs Ketoprofen and its formulation and Aceclofenac its FormulationĢ023.06.02_DR_S.O. 687(E) dt_Omission of Glyceryl Trinitrate and Isosorbide Dinitrate from Schedule P1 and modification in Rule 105Ģ023.07.31_DR_S.O. 686 (E) dt_Inclusion of Oseltamivir and Zanamivir in Schedule H1ĭR_Draft_G.S.R. 4351(E)_Notification of Government AnalystĭR_ Draft_G.S.R. 4834(E)_In compliance to the Jan Vishwas (Amendment of Provisions) Act, 2023Ģ023.10.05_S.O.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |